# Subthalamic Nucleus Stimulation With Directional Leads on Patients With Parkinson Disease at Fluctuations and Dyskinesia Stage

> **NCT05103072** · — · UNKNOWN · sponsor: **Centre Hospitalier Universitaire, Amiens** · enrollment: 13 (estimated)

## Conditions studied

- Parkinson Disease
- Subthalamic Nucleus Stimulation
- Directional Electrodes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05103072
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-21
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 13 (ESTIMATED)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05103072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05103072, "Subthalamic Nucleus Stimulation With Directional Leads on Patients With Parkinson Disease at Fluctuations and Dyskinesia Stage". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05103072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*